chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt expressed feeling increased heart rate( palpitation), and slight headache after being vaccinated. At 10:43 AM HR: 89, RR: 16, BP 142/82, and O2: 97. At 10: 53 Am, HR: 87, RR 18, BP: 127/85, and O2: 97. Pt given water PO once , expressing feeling better and has been walked out to Exit with his wife.
Within an hour: arm pain. Throughout day: tired. Night: severe arm pain and couldn?t get comfortable enough to sleep. 1AM the following day: woke up with fever and muscle pains. Took Tylenol. Next day: nausea, chills, arm pain, fever (up to 101.8), hot flashes, headache. Drank a lot of water.  Night: took Tylenol and was able to sleep. Woke up in a pool of sweat. Tired the next day but felt a lot better - no more fever. Arm pain to the touch.
Thrombocytopenia, Abn LFT's, fever. Varicella rash, increased asthma symptoms.
Redness and swelling of upper arm (more than normal).  Pt could not sleep on that arm for 2 nights, was painful to the touch and warm.
Approx 4 hrs after vaccination patient felt short of breath followed by joint pain, chills, and fever: 102.5 & duration 24 hrs.
After receiving my Moderna Booster the first couple days I had what I would call normal side effects with sore arm.  After a few days woke with severe muscle weakness and shaking, severe bladder inflammation/infection, chills, neuropathy of hands and feet. Spiked blood pressure of 190/98. No fever.
Excruciating pain to tooth; Dry heaving; Headaches; Fatigue; Lymph nodes swollen-right; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right). At the time of the report, TOOTHACHE (Excruciating pain to tooth), RETCHING (Dry heaving), HEADACHE (Headaches), FATIGUE (Fatigue) and LYMPHADENOPATHY (Lymph nodes swollen-right) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Received MMR, VARICELLA & HEP A #1 on 9-4-09.  On 9-14-09 child had fever of 101.0 degrees for 2 days.  On 9-16-09 rash on cheek, nose then trunk, arms.  Mild red pin point rash, has since gone a way.  Child also teething & has ear infection.  Not on any medications.
Chills, body aches, fever 36 hours. Rash started two days after vaccine and lasted approximately 12 hours
tendinitis; few days later had an interaction with another product; This is a spontaneous report from a contactable consumer (patient) reporting for herself received from a Pfizer-sponsored. A female patient of age, 62 (Unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Feb2021 as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection) on an unspecified date as single dose for covid-19 immunisation. On an unspecified date in Feb2021, the patient experienced tendinitis and few days later had an interaction with another product. The clinical course was reported as follows: The patient received the second dose of the Covid vaccine 5 days ago. She received two steroid cortisone shots for tendinitis the previous day. She asked if the cortisone shots will interfere with the efficacy of the vaccine. She received 2 steroid shots in hand five days after covid vaccine and wondering if it is going to diminish efficacy of vaccine. She got her 2nd dose of the Covid vaccine and then a few days later had an interaction with another product and she wanted to report it. She got her 2nd dose and then had a reaction with another product with the vaccine. The outcome of events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
pt recv vax & devel 104 fever, n/v, malaise, arthralgias platelets dec 5000,000 to 145,000;
Achy joints in both shoulders; Swollen lymph nodes (worse on right side/injection side); This is a spontaneous report from a contactable consumer (reporting herself). A 40-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 18Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 19Feb2021, the patient experienced swollen lymph nodes (worse on right side/injection side) and on an unknown date, the patient experienced achy joints in both shoulders. Referred caller to HCP for further discussion. Provided off-label disclaimer. Informed caller that Pfizer was unable to make treatment recommendations. Spoke from attached document CONS-Pfizer-BioNTech COVID-19 Vaccine - timing of Dose 2 (v1.0). Offered to provide state/local health dept. contact information but caller declined stating she has already contacted. The outcome of event was recovering.  Information on the lot/batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Caller  state that first vaccine 12/22 caused fever 100.0, fatigued, muscle aches, pain in arm pit on the vaccinated arm.. Caller went to doctor diagnosed with swollen lymph nodes lasting 12 days. Second Vaccine 1/12 caused high fever, headache, muscle aches and fatigue. Caller used Tylenol and went to be tested for corvid and results were negative. Caller stated that she still does have some numbness in the hand with the swollen lymph nodes. Caller completed vaers report over phone.
sore arm; nausea; diarrhea; woosy; Patient felt as though she had COVID all over again/ felt like she went through the same COVID experience in three days after the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 58 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 22Mar2021 17:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Nov2020, stop date: Nov2020, notes: for about 14 days in Nov2020. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "sore arm"; HEADACHE (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "mild headache"; CHILLS (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "chills/ shivering"; NAUSEA (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "nausea"; FEELING OF BODY TEMPERATURE CHANGE (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "hot, freezing"; DIARRHOEA (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "diarrhea"; PYREXIA (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "fever"; MALAISE (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "sick"; DIZZINESS (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "woosy"; SUSPECTED COVID-19 (non-serious) with onset 24Mar2021 15:00, outcome "unknown", described as "Patient felt as though she had COVID all over again/ felt like she went through the same COVID experience in three days after the vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Clinical course: First dose of the Pfizer COVID vaccine on 22Mar2021 around 5 PM. Patient reported that starting on 24Mar2021 at around 3 PM Wednesday and 25Mar2021 Thursday, she experienced a sore arm, mild headache, chills, nausea, hot, freezing, shivering, couldn't function and diarrhea all day. Patient felt as though she had COVID all over again. Had COVID for about 14 days in Nov2020, and felt like she went through the same experience in three days after the vaccine. Also had a fever, headache, couldn't function and felt like she hit a wall, sick and woosy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Anaphylactic reaction; rash 3.5 x 5 inches below the injection site; A spontaneous report was received from a consumer concerning a 65-year-old female, patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced an anaphylactic reaction and a vaccination site rash.    The patient's medical history included diabetes since an unknown date.  Relevant concomitant medications included an unspecified diabetes medication.   On 06-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 18-Jan-2021, the patient experienced the event anaphylactic reaction and a vaccination site rash 3.5 x 5 inches.  Laboratory details were not provided. Treatment information included fexofenadine and diphenhydramine.  Action taken with mRNA-1273 in response to the events was not reported.   On 23-Jan-2021, the outcome of the events, anaphylactic reaction and vaccination site rash, was considered resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient stated that he vocalized to the vaccinator at the time of injection "I felt that. I really felt that". Patient states that he had immediate pain with no swelling or redness. Patient stated 2 months after injury he told his doctor of the injury during a visit and the recurring pain. Dr. ordered x-ray and Patient started physical therapy. Patient stated that 6 months after claimed injury that he had a MRI of shoulder and that it showed no nerve damage. As of 10/25/21, Patient states that he is still having pain and was referred to a shoulder specialist by his doctor.
I had a sudden dramatic increase of pain in my lower back and right leg. I went to the doctor and had a number of blood tests. MRI, and X-ray. The blood work showed a significant decrease in B-12. I've had B-12 injections, an increase in pain medication, and a nerve blockage. The pain has eased somewhat. I go to a physical therapy and a pain clinic. Last fall I had COVID-19, and the day before I tested positive for COVID-19 I started having pain in my leg which is similar to the pain that I'm feeling now.
Pt had 2 covid vaccines and a booster, later developed covid and was hospitalized and died.
Pain in arm at injection site. Hot and red at injection site. Arm hurts when moving. Aching shoulders, aching knees, overall aching. Stomach upset, felt like throwing up.  Low grade fever, 99.3F. Took Zantac for upset stomach which improved. Afraid to try ibuprofen or acetaminophen due to stomach upset.
This spontaneous report as received from a pharmacy technician refers to a 7-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On 06-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry date: 23-AUG-2019) (dose, frequency and route were not reported) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1802USA001558.
stage 4 ovarian cancer started as pain under right shoulder blade, much abdominal pain, trouble breathing hospitalization for fluid around lung chemotherapy-7 cycles debulking surgery chemotherapy-3 cycles current treatment-avastin infusion every 3-4 weeks
This spontaneous report as received from a consumer (patient's mother) refers to a female patient of unknown age. On an unspecified date in 2008, the patient was vaccinated with GARDASIL dose 1 (dosing details, lot#, expiration date and route unspecified) for prophylaxis. The patient's mother reported that her daughter had been "living with pain" since receiving the vaccine (approximately since 2008). She also mentioned that her daughter experienced muscle pain and migraines after getting the vaccination (onset dates unspecified). It was unspecified whether the daughter had completed the GARDASIL quadrivalent series in 2008 or if she had only received the first or second dose. The events outcome was not provided. No product quality complaint was involved. Causality assessment was not provided. No additional adverse event details were provided. Additional information has been requested.
The patient received the vaccination and at approximately 10 minutes afterwards, the patient was unresponsive and his body had gone limp. He was still breathing but had a pale complexion. This lasted approximately 1 minute and the paramedics came onto the scene to aid the patient.
Patients wife reported on 09/03/20 that her husband experienced severe aching in both legs to the point where he could hardy walk staring one day post vaccine on 09/02/20.  Reported NO fever only extreme leg pain.  Patient reported to MD who encourage patient to call pharmacy.
Varicella zoster onset 11/01/12 over right anterior thigh, right buttock. Hyperesthesia over right flank and RLQ of abdomen. Being treated with Acyclovir, Lidoderm patches, and Vicodin.
spontaneous call. spoke with patient during orenitram consult. patient stated that she was not doing well after receiving her booster of covid-19 Pfizer vaccine on 11/4/21. as a result, she was in the hospital from 11/9/21 to 11/14/2021 due to kidney failure and issues with her organs shutting down. she was not able to take the orentiram while in the hospital. she had to restart the medication and titrate at a slower rate due to inflammation in the stomach. current dose is 1.5mg by mouth three times daily. her doctor is aware of the situation there is no other information known.
Pt developed joint pain and swelling after IZ at 5-6 months. Current dx is JRA. A follow report received 10/9/2000 adds: Arthralgias first reported 7/23/1998; edema first reported 8/21/1998. Pt's disease ongoing.
Patient had shingles shot yesterday. She came in today complaining of an injection site reaction. She states that her left arm is sore and hot to touch. She showed me her left arm where the reaction occurred. There was a red circle about the size of an orange and some bruising. Patient denied dizziness, shortness of breath, swelling, difficulty breathing, or any other symptoms. She said it doesn't itch and does not have any rashes or redness on any other area of the body. I provided her a VIS, highlighted the section on injection site reactions, went over it with her and explained that injection site reactions, such as the one she is having, can occur. I introduced her to follow up with her prescriber or seek medical attention if she experiences any dizziness, shortness of breath, swelling, difficulty breathing, signs of anaphylaxis or serious reaction.
Dose didn't get in patient's arm instead it went into eyes of vaccine provider.; Mal-function of syringe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of OCCUPATIONAL EXPOSURE TO PRODUCT (Dose didn't get in patient's arm instead it went into eyes of vaccine provider.) and DEVICE MALFUNCTION (Mal-function of syringe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 30-Mar-2021, the patient experienced OCCUPATIONAL EXPOSURE TO PRODUCT (Dose didn't get in patient's arm instead it went into eyes of vaccine provider.) and DEVICE MALFUNCTION (Mal-function of syringe). On 30-Mar-2021, OCCUPATIONAL EXPOSURE TO PRODUCT (Dose didn't get in patient's arm instead it went into eyes of vaccine provider.) and DEVICE MALFUNCTION (Mal-function of syringe) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  This report refers to a case of occupational exposure to product and device malfunction for mRNA-1273, lot # 018B21A  with no associated AEs.; Sender's Comments: This report refers to a case of occupational exposure to product and device malfunction for mRNA-1273, lot # 018B21A  with no associated AEs.
The injection site was itchy; injection site was itchy, then over time grew into a welt; It is now 10 days post injection, the welt is warm, hard and about 4.5mm and getting bigger each day; It is now 10 days post injection, the welt is warm, hard and about 4.5mm and getting bigger each day; This is a spontaneous report from a contactable other hcp (patient). A 49-year-old male patient received the first dose of BNT162B2 (Lot number: EK5730), intramuscular on 27Dec2020 12:00 at single dose in the left arm for COVID-19 immunization. Medical history included allergies: Sulfur and Acrylates from an unknown date. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), loratadine (CLARITINE), omeprazole, metoprolol, ibuprofen (ADVIL) and paracetamol (TYLENOL). The patient previously took cefalexin (KEFLEX) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Dec2020, the injection site was itchy, then over time grew into a welt. It is now 10 days post injection, the welt is warm, hard and about 4.5mm and getting bigger each day. He stated that he is seeing his physician tomorrow. Treatment for the events were unknown. The patient underwent lab tests and procedures which included Nasal Swab: negative on 31Dec2020. The outcome of the events was unknown.
Had MMR vaccine at 11:30am on 9/4/02. That evening at 9pm noted rash on trunk and extremities. Saw MD on 9/5/02. Dx urticaria. Rx for medrol dose pack given instructed to use Benadryl 50mg TID. Rec. not getting 2nd MMR.
Shingles; This is a spontaneous report from a contactable consumer or other health professional. A 28-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Manufacturer: Pfizer/BioNTech; Lot: EN5318) via an unspecified route of administration on 11Feb2021 in Arm Right at single dose for COVID-19 immunisation. Medical history included asthma, seasonal allergy (seasonal allergies) from an unknown date and unknown if ongoing. Historical vaccination included at age of 28 years first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Manufacturer: Pfizer/BioNTech; Lot: EL3247) on 21Jan2021 in Left arm at single dose for COVID-19 immunisation. Concomitant medications included cetirizine and fluticasone propionate (FLONASE) taken for an unspecified indication, start and stop date were not reported. On 14Feb2021, The patient experienced shingles. The action taken in response to the event for BNT162B2 was not applicable. Therapeutic measures were taken as a result of shingles. The outcome of event was recovering.
severe h/a, hands & feet swollen, legs aches-treated w/APAP/ASA or Advil, & DPH;
This serious spontaneous consumer report (initial receipt 09-Jan-2015) concerns a female patient. On an unspecified date, years ago, the patient received unspecified flu vaccine (manufacturer and batch number not reported). On an unspecified date, after vaccination, the patient could not lift her arm where the injection was administered. Soon afterwards, she felt like "she was getting surgery, where she felt sleepy, but could hear people's voices but could not speak." She somehow made it to an emergency room and was administered epinephrine and her symptoms resolved. The patient stated that she now had low tolerance towards the swine in the flu vaccines. The outcome was reported as resolved. Reporter comments: The reporter assessed the events as related to the use of flu vaccine.
Right leg at injection site swollen, red area approximately .5 inch around site, warm to touch, symptoms increased from 5/4 until morning of 5/5/04. Pt brought into office for appointment.
Upon waking up at 2 AM, I started feeling terrible. I had chills and it lasted for hours. I had a lot of pain in my right arm. I had some stabbing pains throughout my body. I had extreme fatigue.  I had stomach cramps.
Soreness at injection site severe within 6 hours- continued for 2 days (currently on-going).  Joint stiffness experienced approx 6-8 hrs post vaccine.  Extreme fatigue set in approx 18 hours post injection with mild fever of 99.5.  Fever of 102 at approximately 7PM 4/22.  Tylenol administered with sleep, fever broke approx 3AM 4/23.  No further fatigue, stiffness, or fever as of noon 4/23.
received 1st Shingrix administered on January 27, 2020 and 2nd Shingrix vaccine administered on March 9, 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number 43SG5, expiry date 13-OCT-2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on January 27, 2020).   On 09-MAR-2023, the patient received the 2nd dose of Shingrix. On 09-MAR-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: received 1st Shingrix administered on January 27, 2020 and 2nd Shingrix vaccine administered on March 9, 2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 11-AUG-2023 The pharmacist reported that a patient received 1st Shingrix administered on January 27, 2020 and 2nd Shingrix vaccine administered on March 9, 2023 which led to drug dose administration interval too long. Pharmacist stated that patient's physician told him that the 1st Shingrix vaccine was invalid and he needed to come in for a 3rd Shingrix vaccines. 3rd dose of vaccine not administered at time of reporting. The reporter consented to follow up.